scispace - formally typeset
Journal ArticleDOI

Pathophysiology of diurnal drooling in Parkinson's disease

Reads0
Chats0
TLDR
Patients with Parkinson's disease with distinct diurnal saliva loss and without drooling complaints appear to compensate by increasing their swallowing frequency, much like the increased cadence that is used to compensate for stepping akinesia.
Abstract
Drooling is an incapacitating feature of Parkinson's disease. Better pathophysiological insights are needed to improve treatment. In this study, we tested the hypothesis that the cause of drooling is multifactorial. We examined 15 patients with Parkinson's disease with distinct diurnal saliva loss ("droolers") and 15 patients with Parkinson's disease without drooling complaints ("nondroolers"). We evaluated all factors that could potentially contribute to drooling: swallowing capacity (maximum volume), functional swallowing (assessed with the dysphagia subscale of the Therapy Outcome Measures for rehabilitation specialists), unintentional mouth opening due to hypomimia (Unified Parkinson's Disease Rating Scale item), posture (quantified from sagittal photographs), and nose-breathing ability. We also quantified the frequency of spontaneous swallowing during 45 minutes of quiet sitting, using polygraphy. Droolers had more advanced Parkinson's disease than nondroolers (Unified Parkinson's Disease Rating Scale motor score 31 vs 22; P=.014). Droolers also scored significantly worse on all recorded variables except for nose breathing. Swallowing frequency tended to be higher, possibly to compensate for less efficient swallowing. Logistic regression with adjustment for age and disease severity showed that hypomimia correlated best with drooling. Linear regression with hypomimia as the dependent variable identified disease severity, dysphagia, and male sex as significant explanatory factors. Drooling in Parkinson's disease results from multiple risk factors, with hypomimia being the most prominent. When monitored, patients appear to compensate by increasing their swallowing frequency, much like the increased cadence that is used to compensate for stepping akinesia. These findings can provide a rationale for behavioral approaches to treat drooling.

read more

Citations
More filters
Journal ArticleDOI

Gastrointestinal Dysfunction in Parkinson’s Disease

TL;DR: The clinical features of gastrointestinal dysfunction in Parkinson’s disease are described and information regarding the potential role of the enteric nervous system and the gut microbiome in the genesis of Parkinson's disease is addressed.
Journal ArticleDOI

Drooling in Parkinson's disease: A review

TL;DR: Local injection with botulinum toxin serotypes A and B into major salivary glands is most effective to reduce drooling.
Journal ArticleDOI

Gut dysfunction in Parkinson's disease.

TL;DR: The extensive involvement of the gut in PD even in its early stages has led to the evaluation of enteric α-synuclein as a possible biomarker of early PD, and one important aspect of gut dysfunction is its contribution to the clinical fluctuations in PD.
Journal ArticleDOI

Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease

TL;DR: Current clinical and pathological evidence of gut involvement in PD is provided by summarizing the changes in gut microbiota composition and gut inflammation associated with its pathogenesis.

Instituto superior de ci ncias da sa⁄de

Egas Moniz
TL;DR: The regulation of feeding behavior also involves the monoamines dopamine, noradrenalin and serotonin involved in the reward center, a system that values the intake by the feeling of pleasure, and the endocannabinoid system that protects from anxiety and stimulates feeding.
References
More filters
Journal ArticleDOI

[Parkinson's disease].

Journal ArticleDOI

Gender differences in Parkinson’s disease

TL;DR: The results suggest that the development of symptomatic PD may be delayed by higher physiological striatal dopamine levels, possibly due to the activity of oestrogens, and a more benign phenotype in women with PD is suggested.
Journal ArticleDOI

The pathogenesis of gait hypokinesia in Parkinson's disease

TL;DR: It was concluded that regulation of stride length is the fundamental problem in gait hypokinesia and the relative increase in cadence exhibited by PD subjects is a compensatory mechanism for the difficulty in regulating stride length.
Journal ArticleDOI

Parkinson's Disease Symptoms: The Patient's Perspective

TL;DR: It is suggested that as the disease advances the most troublesome issues that patients perceive are the lack of response to medication and the nonmotor aspects of the disease, highlighting the importance of assessment and patient‐centered management in the follow-up of these patients.
Related Papers (5)